搜尋結果
Cheap Ozempic Copycats Are Suddenly Everywhere. Are They Safe?
Bloomberg· 3 日前Cheap Ozempic Copycats Are Suddenly Everywhere. Listen to the Big Take podcast to find out why ...
Pfizer’s Treatment for Bleeding Disorder Meets Goal in Key Trial
Bloomberg· 3 日前Have a confidential tip for our reporters? Pfizer Inc.’s gene therapy for a severe ...
Author Post: The Longevity Movement: What to Make of the Hype
Forbes· 2 日前High-end gym chain Equinox introduced a longevity program with a $40,000 annual membership ... ...
Australia's Mayne Pharma sues Indian drugmaker Sun Pharma over patent infringement
Reuters· 1 日前Mayne Pharma has filed a lawsuit against India's Sun Pharma over infringements of patents ...
What Technologies Will Shape The World Of The Future ?
Forbes· 3 日前While investors need to be alert to this as a crucial factor for portfolios, there is also a .. ...
AbbVie lifts 2024 profit forecast, shares hit record high
Reuters· 1 日前, opens new tab increased its profit forecast for 2024 on Thursday after reporting strong sales ...
... Big Tobacco pushes further toward cigarette alternatives. Here’s who could come out on top ...
CNBC· 6 日前The news came on the heels of the announcement ...
Hims & Hers Adds Longtime Novo Executive to Board Amid Weight-Loss Bet
Bloomberg· 5 日前Have a confidential tip for our reporters? Hims & Hers Health Inc. is adding longtime Novo ...
Philip Morris delays U.S. heated tobacco device pilot to fourth quarter
Reuters· 3 日前, opens new tab pushed the test-launch of its heated tobacco device, IQOS, in the ...
Is An Earnings Beat In The Cards For Merck Stock?
Forbes· 22 小時前Merck (NYSE: MRK) will report its Q2 2024 results on Tuesday, July 30. As usual, Keytruda will ...